Walter J. Thomsen
Directeur Général chez SOEX Processing Germany GmbH
Profil
Walter J.
Thomsen is currently the Co-Managing Director at SOEX Processing Germany GmbH.
Previously, he worked as the Chief Financial Officer & Director-Administration at bionamics GmbH and as the President, Chief Executive & Financial Officer at Proteo, Inc. Thomsen holds an MBA from the University of Kiel.
Postes actifs de Walter J. Thomsen
| Sociétés | Poste | Début |
|---|---|---|
SOEX Processing Germany GmbH
 SOEX Processing Germany GmbH Specialty StoresRetail Trade Part of Soex Textil-Vermarktungs GmbH, SOEX Processing Germany GmbH supplies used materials and residues. The company is based in Bitterfeld-Wolfen, Germany. The CEOs are Walter J. Thomsen, Markus Naumann, Peters Martin. The German company was founded in 1999. | Directeur Général | - |
Anciens postes connus de Walter J. Thomsen
| Sociétés | Poste | Fin |
|---|---|---|
| PROTEO, INC. | President | 07/11/2005 |
bionamics GmbH
 bionamics GmbH Miscellaneous Commercial ServicesCommercial Services bionamics GmbH was an asset management. It used to acquire or license assets in the pre-clinical phase, redirect some as assets for new and appropriate customers or develops these into the clinics, and commercializes the projects into the pharma and biotech industry. The firm offers represent a unique project based investment opportunity. It identifies and evaluates projects from academia, biotech and pharmaceutical companies. The company was headquartered in Kiel, Germany. | Directeur Financier/CFO | - |
Formation de Walter J. Thomsen
| University of Kiel | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Proteo, Inc.
 Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
bionamics GmbH
bionamics GmbH Miscellaneous Commercial ServicesCommercial Services bionamics GmbH was an asset management. It used to acquire or license assets in the pre-clinical phase, redirect some as assets for new and appropriate customers or develops these into the clinics, and commercializes the projects into the pharma and biotech industry. The firm offers represent a unique project based investment opportunity. It identifies and evaluates projects from academia, biotech and pharmaceutical companies. The company was headquartered in Kiel, Germany. | Commercial Services |
SOEX Processing Germany GmbH
SOEX Processing Germany GmbH Specialty StoresRetail Trade Part of Soex Textil-Vermarktungs GmbH, SOEX Processing Germany GmbH supplies used materials and residues. The company is based in Bitterfeld-Wolfen, Germany. The CEOs are Walter J. Thomsen, Markus Naumann, Peters Martin. The German company was founded in 1999. | Retail Trade |
